WAGO Annual Meeting

2024 WAGO Annual Meeting

Save the Date — Wednesday, June 12 – Saturday, June 15

Seattle, Washington

Fairmont Olympic Hotel Seattle
4:00 PM – 7:30 PM

Registration Open

Exhibit & Poster Set-Up

6:00 pm – 7:30 pm

Welcome Reception

6:30 AM – 8:00 AM


6:30 PM – 12:00 PM

Registration Open

8:00 AM – 8:10 AM

Welcome & Opening Remarks

8:10 AM -9:15 AM

General Session 1

9:15 AM – 9:30 AM


9:30 AM – 10:35 AM

General Session 2

10:35 AM – 12:05 PM

ASCO Update

Kathleen Moore, MD, Stephenson Cancer Center, University of Oklahoma Health Sciences Center

12:05 PM – 1:50 PM

Industry Supported Symposium

5:30 PM – 7:00 PM

Networking Event

6:30 AM – 8:00 AM


6:30 AM – 2:00 PM

Registration Open

7:00 AM – 8:00 AM

Trainee Session

7:00 AM – 8:00 AM

WAGO Business Meeting

8:15 AM – 9:20 AM

General Session 3

9:20 AM – 9:35 AM


9:35 AM – 10:25 AM

General Session 4

10:25 AM – 11:25 AM

Tumor Board

11:40 AM – 1:10 PM

Industry Supported Symposium

6:00 PM – 9:00 PM

President’s Reception

6:15 AM – 8:00 AM


6:15 AM – 12:00 PM

Registration Open

6:15 AM – 6:45 AM

Poster Presentations & Exhibit Hall Open

6:45 AM – 7:00 AM

WAGO 2025 Annual Meeting Location Announcement

7:00 AM – 8:00 AM

Presidential Lecture

8:30 AM – 9:20 AM

General Session 5

9:20 AM – 9:35 AM


9:35 AM – 11:45 AM

General Session 6

11:45 AM – 11:55 AM

Closing Remarks

General Session 1

General Session 2

General Session 3

General Session 4

General Session 5

General Session 6

Poster #1:

A Roadmap to Safety: Decreased Intraoperative Injury with a Multidisciplinary Approach to Placenta Accreta
Presenting Author: Rachel Levy, MD – UCSF

Poster #2:

COVID-19 vaccination in cancer patients receiving chemotherapy: does vaccination increase the risk of hypersensitivity reactions?
Presenting Author: Sierra M. Treiman, MD – Creighton Ob/Gyn Residency – Phoenix Campus

Poster #3:

Lenvatinib for Endometrial Cancer: Reducing Healthcare Disparities and Emphasizing Equitable Medication Access through Quality Improvement
Presenting Author: Steven Baine Holloway, MD, FACOG – UT Southwestern Medical Center

Poster #4:

An evidence-based approach to prescribing post-discharge opioids after laparotomy
Presenting Author: Allison H. Kay, MD – UCSF / KP SFO

Poster #5:

Effect of perioperative app on use of emergency medical services for patients recovering from laparotomy
Presenting Author: Megan Marshalla, MD – Rush University Medical Center

Poster #6:

Beyond Rounds—Improving Physician Wellness on the Gyn-Oncology Service through Meaningful Connection
Presenting Author: Nicole Rubin, MD – UCSF Division of Gynecologic Oncology

Poster #7:

If you don’t use it, lose it: Reducing over prescription of opioids at discharge
Presenting Author: Alison McGough-Madueña, MD, MPH – UCSF Division of Gynecologic Oncology

Poster #8:

Non-English language as a barrier to postoperative pain management
Presenting Author: Rachel Levy, MD – UCSF

Poster #9:

Two-year follow up on the impact of the COVID-19 pandemic on outcomes in gynecologic oncology patients
Presenting Author: Kati Turner, MD, MPH – Barnes-Jewish Hospital/Washington University in St. Louis

Poster #10:

Disparities in breast cancer screening adherence among Hispanic women who receive cervical cancer screening
Presenting Author: Grace R. Ge – McGovern Medical School at UTHealth Houston

Poster #11:

Planned Interim Analysis of a Randomized Trial Comparing Epidural to Surgical Site Infiltration with Liposomal Bupivacaine for Gynecologic Oncology Patients Undergoing Laparotomy
Presenting Author: Dana Hazimeh, MD – Johns Hopkins University – Department of GYN/OB

Poster #12:

Panniculectomy to Facilitate Minimally Invasive Hysterectomy is Effective for Severely Obese Patients Undergoing Gynecological Oncological Surgery
Presenting Author: Roxanne AR. Manek, DO – Kaiser Permenante

Poster #13:

Identifying Barriers to Initiation of Pelvic Floor Therapy: Life After Gynecologic Cancer
Presenting Author: Caroline Zhang, MD – University of Texas McGovern School of Medicine–UT Health

Poster #14:

Gynecologic and Breast Cancer Patient Experiences with Scalp Cooling to Reduce Alopecia
Presenting Author: Sujata Eden Tewari – St. Joseph Hospital, Orange, California 

Poster #15:

Poor Self-Rated Mental Health Affected Cervical Cancer Screening Rates During the COVID-19 Pandemic
Presenting Author: Karen E. Haney, MD – University of Texas Health Science Center at Houston

Poster #16:

The Clot Thickens: Identifying Risk Factors for VTE in Metastatic and Recurrent Cervical Cancer
Presenting Author: Carson C. Edwards, MD – University of Texas Southwestern

Poster #17:

Do the Peters criteria hold up for adenocarcinoma? A retrospective database study evaluating the effect of histology on outcomes in surgically-treated high-risk early stage cervical cancer
Presenting Author: Danielle Greenberg, MD – University of California, Irvine

Poster #18:

Prognosis of cervical cancer when diagnosed during pregnancy
Presenting Author: Lydia M. Makepeace, MD – University of Texas at Southwestern Medical Center

Poster #19:

The impact of social media on anxiety and depression among patients with neuroendocrine carcinoma of the cervix: A Neuroendocrine Cervical Tumor Registry (NeCTuR) study
Presenting Author: Reem Saab, MD – The University of Texas MD Anderson Cancer Center

Poster #20:

Low-grade endometrioid endometrial cancer with adnexal metastasis: Possible de-escalation candidate for adjuvant therapy?
Presenting Author: Andrew Vallejo, MD – University of Southern California

Poster #21:

Use of postoperative opioids in patients undergoing robotic hysterectomy for endometrial cancer with or without abdominal wall block
Presenting Author: Ioana L. Bondre, MD – University of California San Diego

Poster #22:

Obese microenvironmental signaling and junctional protein disruption in endometrial cells: an early pro-oncogenic change?
Presenting Author: Megan E. Ross, MD, MPH – University of Texas Health Science Center San Antonio

Poster #23:

Immunotherapy in recurrent endometrial cancer: who derives benefit?
Presenting Author: Ayesha Kar-Kasal, MD – University of Chicago Medical Center

Poster #24:

Characterization of genomic and social determinants of health in the TP53 mutational landscape of non-cancerous endometrium during the lifespan of Black and White individuals
Presenting Author: Eric Rios-Doria, MD – University of Washington

Poster #25:

No survival difference in patients receiving radical hysterectomy vs. extrafascial hysterectomy in stage II-IV endometrial cancer patients – a multivariate analysis
Presenting Author: Teresa Palkowski, MD – UCSF Fresno

Poster #26:

Intraoperative radiation therapy in the treatment of recurrent cervical and endometrial cancer: analysis of postoperative complications
Presenting Author: Lindsay N. Howlett, BS – Mayo Clinic

Poster #27:

Attenuation of COVID-19 infection among patients with endometrial and cervical cancer receiving immunotherapy
Presenting Author: Natalie L. Shammas, MD – Adventist Health White Memorial Medical Center

Poster #28:

Decision-making regarding ovarian cancer risk-reduction among women of color who carry a BRCA mutation
Presenting Author: Emmeline Friedman, MD– University of New Mexico Health Sciences Center

Poster #29:

Clinical and pathological factors that predict survival in patients undergoing pelvic exenterations for gynecological malignancies
Presenting Author: Priyal P. Fadadu, MD, MS – Mayo Clinic

Poster #30:

HPV vaccination rates among women 27-45 rose more slowly after ACOG’s statement recommending shared decision making
Presenting Author: Ioana L. Bondre, MD – University of California San Diego

Poster #31:

Severe maternal morbidity is increased among pregnant persons with gynecological malignancies
Presenting Author: Katherine C. Fitch, MD – Oregon Health & Sciences University

Poster #32:

Evaluation of pseudoprogression on immune checkpoint inhibitor therapy in gynecologic cancers
Presenting Author: Adeola Akapo, MD – University of Colorado

Poster #33:

Characteristics and management of malignant mesonephric tumors of the female genital tract: a surveillance, epidemiology, and end results database study
Presenting Author: Danielle Greenberg, MD – University of California, Irvine

Poster #34:

Surgical outcomes for robotic-assisted single-site hysterectomy as compared to multi-site hysterectomy: a single institution retrospective study
Presenting Author: Ravali A. Reddy, MD – Stanford School of Medicine, Department of Obstetrics and Gynecology

Poster #35:

Trends in estimated percent of patients with epithelial ovarian cancer eligible for and responding to PARP inhibitors over time
Presenting Author: Erica V. Carballo, MD – Vanderbilt University Medical Center

Poster #36:

Somatic NF1 alterations as potential biomarker for response to immune checkpoint inhibition in recurrent ovarian cancer
Presenting Author: Ashley S. Moon, MD – Stanford University School of Medicine

Poster #37:

Assessment of malignancy type-specific COVID-19 case-fatality in the United States
Presenting Author: Andrew Vallejo, MD – University of Southern California

Poster #38:

Therapeutic Opportunities in the Master Transcription Factor Circuitries of Clear Cell Carcinomas
Presenting Author: Nolan J. Kinne, MD– Cedars Sinai Medical Center

Poster #39:

Comparison of contemporary management and outcomes of patients with transitional cell carcinomas and malignant Brenner tumors of the ovary
Presenting Author: Katherine Coakley, MD – University of California, San Diego

Poster #40:

Trends in ovarian cancer incidence and incidence-based mortality: a 15-year population-based analysis
Presenting Author: Sahana Somasegar, MD – Stanford University School of Medicine

Poster #41:

Overexpression of the microRNA let-7i does not consistently enhance sensitivity to cisplatin in vitro in patient-derived epithelial ovarian carcinoma samples
Presenting Author: Nora Badiner, MD – Loma Linda University Medical Center

Poster #42:

Chemical inhibition of SWI/SNF induces transformed growth in non-mutant cells, mimicking the effects of a SMARCA4 mutation associated with small cell carcinoma of the ovary, hypercalcemic type.
Presenting Author: Adam J. Krieg, PhD – OHSU/ONPRC

Poster #43:

UP-NEXT (ENGOT-Ov71-NSGO-CTU/GOG-3049): A Study of Upitifamab Rilsodotin (UpRi), a NaPi2b-directed Antibody Drug Conjugate (ADC) in Platinum-Sensitive Recurrent Ovarian Cancer
Presenting Author: Debra L. Richardson, MD, FACS, FACOG, Stephenson Cancer Center, OU Health

Poster #44:

In vitro chemosensitivity of patient-derived ovarian cancer samples is not correlated with homologous recombination deficiency, platinum sensitivity, or cancer stem cell frequency
Presenting Author: Nora Badiner, MD – Loma Linda University Medical Center

Poster #45:

Relative Incidence of Uterine Cancer in Black Patients Compared to White Patients in the US
Presenting Author: Deanna H. Wong, MD, MPH– UCLA

Poster #46:

Cancer Survival in Women Diagnosed with Leiomyosarcoma of the Uterus
Presenting Author: Christina Curtin, MD – University of Texas Southwestern


WAGO 2025 Annual Meeting
Wednesday, June 18 –  Saturday, 21, 2025